|
AsacolDrug - Asacol The trade name of the product as shown on the labeling.
Dosage -
TABLET, DELAYED RELEASE; ORAL
Active Ingredient(s) -
Mesalamine
Strength -
400MG
Applicant -
PROCTER AND GAMBLE
New Drug Application (NDA) Number -
019651
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 31, 1992
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co
Asacol
Pentasa 250mg Capsule, Extended Release; Oral
Pentasa 500mg Capsule, Extended Release; Oral Mesalamine 4gm/60ml Enema; Rectal Mesalamine 4gm/60ml Enema; Rectal Rowasa 4gm/60ml Enema; Rectal Canasa 1gm Suppository; Rectal Canasa 500mg Suppository; Rectal Rowasa 500mg Suppository; Rectal Asacol 400mg Tablet, Delayed Release; Oral Mersalyl-theophylline 100mg/ml;50mg/ml Injectable; Injection NewDrugInformation |